Malignant Small Intestinal Neoplasm — Trials

Malignant Small Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

279 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 50
Recruiting: 31
Ph III recruiting: 3
Growth YoY: —
Industry share: 6%
Top sponsor: Minia University
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04566393	Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies	available	—	—	xCuresINDUSTRY	1	Jun 4, 2026	clinicaltrials

Data updated 23 days agoSource updated Jun 4, 2026source: clinicaltrials